Skip to product information
1 of 2

Zoetis

West Nile-Innovator + EWT

West Nile-Innovator + EWT

Regular price $38.95 USD
Regular price Sale price $38.95 USD
Sale Sold out
Shipping calculated at checkout.
NOTIFY ME WHEN IN STOCK
Size

Please see shipping information regarding vaccines before placing order.

Zoetis West Nile Innovator + EWT is for the vaccination of healthy horses as an aid in the prevention of viremia caused by West Nile Virus, and as an aid in the prevention of equine encephalomyelitis due to Eastern and Western viruses, and tetanus. Equine West Nile Virus combination vaccine. For the vaccination of healthy horses as an aid in the prevention of viremia caused by West Nile Virus, and as an aid in the prevention of equine encephalomyelitis due to Eastern and Western viruses, and tetanus.

EFFICACY: Efficacy of the West Nile fraction was demonstrated in 10-month-old horses that received two doses of the vaccine and were challenged one-year post-vaccination with West Nile virus. The vaccine protected 95% of the vaccinates against viremia, while 82% of the controls were viremic.

DOSE: Horses, inject one 1 mL dose intramuscularly using aseptic technique. Administer a second 1 mL dose 3 to 4 weeks after the first dose. A 1 mL booster dose should be given annually. Early revaccination may be advisable when horses are faced with an outbreak or with other conditions which might make heavy exposure likely.

Manufacturer and/or Label Information

ZOETIS INC.
333 PORTAGE STREET, KALAMAZOO, MI, 49007
Telephone: 269-359-4414
Customer Service: 888-963-8471
Website: www.zoetis.com
THIS SERVICE AND DATA ARE PROVIDED "AS IS". DVMetrics assumes no liability, and each user assumes full risk, responsibility, and liability, related to its use of the DVMetrics service and data. See the Terms of Use for further details.
West Nile-Innovator® + EWT

Zoetis

Encephalomyelitis-West Nile Virus Vaccine

Eastern & Western, Killed Virus

Tetanus Toxoid

This product has been shown to be effective for the vaccination of healthy horses 10 months of age or older against viremia caused by West Nile virus; encephalomyelitis caused by Eastern and Western viruses; and tetanus. A duration of immunity of at least 12 months against West Nile virus has been demonstrated. Duration of immunity against the remaining fractions is unknown. For more information regarding efficacy and safety data, go to productdata.aphis.usda.gov.

Field safety testing has demonstrated that this product is safe for use in horses 3 months of age or older. Efficacy has not been established in foals 3 months of age. This product is also safe for use as a single dose during the third trimester of pregnancy.

Directions: Shake well. Aseptically administer 1 mL intramuscularly. Healthy horses should receive two doses administered 3-4 weeks apart. For advice on revaccination frequency or in the face of stress or exposure, contact your veterinarian or the manufacturer.

Precautions: Store at 2°-8°C. Prolonged exposure to higher temperatures and/or direct sunlight may adversely affect potency. Do not freeze. Use entire contents when first opened. Transient local reactions may occur at the injection site. Do not vaccinate within 21 days before slaughter. Contains formalin, thimerosal, neomycin, and polymyxin B as preservatives. Do not mix with other products. In case of human exposure, contact a physician.

Technical inquiries should be directed to Zoetis Inc. Veterinary Services, (888) 963-8471.

Remove serial number and expiration date label and place on the animal’s medical chart.

VLN 190/PCN 48W5.24

Zoetis Inc., Kalamazoo, MI 49007, USA

1 mL

1 Dose

40038408

10 mL

10 Doses

40038409

CPN: 3690344.5
COLORADO SERUM COMPANY4950 YORK STREET, P.O. BOX 16428, DENVER, CO, 80216-0428Telephone: 303-295-7527Order Desk: 800-525-2065Fax: 303-295-1923Website: www.colorado-serum.comEmail: colorado-serum@colorado-serum.comTHIS SERVICE AND DATA ARE PROVIDED "AS IS". DVMetrics assumes no liability, and each user assumes full risk, responsibility, and liability, related to its use of the DVMetrics service and data. See the Terms of Use for further details.

TETANUS TOXOID-CONCENTRATED

Colorado Serum

Adjuvanted

GENERAL INFORMATION: This product has been shown to be effective for the vaccination of healthy horses, cattle, sheep, goats, and swine against tetanus. This product was licensed prior to the requirement to establish a minimum age for use. The duration of immunity is unknown. For more information regarding efficacy and safety data, see productdata.aphis.usda.gov.

Safety in pregnant animals is unknown.

Tetanus Toxoid is prepared by detoxifying tetanus toxin in such a manner as to allow the antigenic properties to remain intact. Product is purified, concentrated and adjuvanted to provide a low dose effective immunizing agent.

Each serial is tested for purity, safety, and potency in accordance with USDA requirements.

Tetanus is caused by a neurotoxin produced by growth of Clostridium tetani, an anaerobic (lives without air) micro-organism, in necrotic tissue. Affected animals become stiff, have difficulty swallowing, and have an increased pulse rate. Breathing is labored. Spasmodic contractions of the muscular system occur, such as contracting muscles of the jaw.

Spasmodic contractions of the muscular system occur, such as contracting muscles of the jaw. Thus, the term “lockjaw” is often used. Legs and tail are often stiff with abdominal muscles contracted. Tetanus stricken animals may be unusually sensitive to light and heat. Temperature of the animal generally remains normal, elevating only shortly before death.

Protective antibody levels usually occur about two weeks after the second injection of the primary immunization series. In contrast, administration of Tetanus Antitoxin is recommended for immediate, emergency, passive treatment of exposed animals with unknown vaccination history or with signs of tetanus infection.

DIRECTIONS: Do not vaccinate within 21 days before slaughter. Store at 2-8° C. Do not freeze. Do not mix with other products. Shake well before use. Use entire contents when first opened.

PRECAUTIONS: A transitory local reaction may occur at injection site. Anaphylactoid reaction may occur following administration of products of this nature. If noted, administer adrenalin or equivalent. In case of human exposure, consult a physician.

DOSAGE & ADMINISTRATION: For primary immunization, two doses should be administered subcutaneously or intramuscularly approximately 30 days apart. Use intramuscularly for horses as local reactions are more likely to occur if injected subcutaneously.

Horses: 1 ml IM

Cattle: 1 ml SC or IM

Sheep, Goats, Swine: 0.5 ml SC or IM

Historically, annual single dose revaccination has been recommended. Contact veterinarian for advice.

OTHER INFORMATION: Contains thimerosal and formalin as preservatives. Tetanus Toxoid Concentrate is available in single dose size packaged 10 vials to the carton, and in 10 dose vials.

THE PEAK OF QUALITY SINCE 1923

VLN: 188 / PCN: 8601.00

COLORADO SERUM COMPANY, 4950 York Street, Denver, Colorado 80216

303-295-752

www.colorado-serum.com

Contact us for information on other Colorado Serum Company products. Fine Veterinary Products since 1923.

FOR VETERINARY USE ONLY

 

 

Order #

10 - 1 ml vials

10 - 1 dose vials

11411

10 ml

10 doses

11415

CPN: 1101033.3

Products

Dimensions

Care information

Customer Reviews

Be the first to write a review
0%
(0)
0%
(0)
0%
(0)
0%
(0)
0%
(0)
View full details

Customer Reviews

Be the first to write a review
0%
(0)
0%
(0)
0%
(0)
0%
(0)
0%
(0)